Not recruiting
B-cell lymphoma+5
Not recruitingStudy on the Effects and Safety of Odronextamab for Adults with Previously Treated B-cell Non-Hodgkin Lymphoma
InvestigationalNo placebo
Study on the Effects and Safety of Odronextamab for Adults with Previously Treated B-cell Non-Hodgkin Lymphoma
InvestigationalNo placebo
- Disease:B-cell lymphomaDiffuse large B-cell lymphoma+4
- Substances:Odronextamab
Countries:
France
France- Participants:18–64 years · 65+ years
- Substances:Odronextamab
- Sponsor:Regeneron Pharmaceuticals Inc.



